GL1X · GenesisL1 explorer

MolNFT v1 · #169323 · protein

Crystal structure of JAK2 with compound 11

6X8E · Tyrosine-protein kinase JAK2: “Crystal structure of JAK2 with compound 11”. X-ray diffraction, 1 ligand (UWP), 5 pockets (best druggability 0.72). MolNFT v1 #169323 on GenesisL1: 3D structure, binding sites and pockets in GL1X.

PDB
6X8E
Type
protein
Length
555 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Tyrosine-protein kinase JAK2
EC
2.7.10.2
UniProt
O60674
Ligands
UWP
Pockets
5 · best druggability 0.72

Structure

x-ray diffraction · 2 distinct chains · 44% helix, 20% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ATyrosine-protein kinase JAK2 (EC 2.7.10.2)protein27444% helix, 20% strandO60674
BTyrosine-protein kinase JAK2 (EC 2.7.10.2)protein28144% helix, 20% strandO60674

Ligands and binding sites

  • UWP · [3-{4-[6-(1-methyl-1H-pyrazol-4-yl)pyrazolo[1,5-a]pyrazin-4-yl]-1H-pyrazol-1-yl}-1-(2,2,2-trifluoroethyl)azetidin-3-yl]acetonitrile · ligand · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

5 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
15580.720.8156UWP
24850.700.8048UWP
31540.480.7726empty
4940.430.7925empty
5500.240.7317empty

Interfaces

1 interface between chains.

  • A–B · 285 Ų buried · 3 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 4 modified (phosphorylation).

Compared structures

  • 6X8E · Crystal structure of JAK2 with Compound 11 · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.